Daniel Newman Mendelson Champions Oncology, Inc. (CSBR) insider trading activity

Daniel Newman Mendelson is Director of CHAMPIONS ONCOLOGY, INC.. Currently has a direct ownership of 198,625 shares of CSBR, which is worth approximately $1.37 Million. The most recent transaction as insider was on Jan 12, 2024, when has been sold 1,000 shares (Common Stock) at a price of $6.5 per share, resulting in proceeds of $6,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 199K

0% 3M change

9.93% 12M change

Total Value Held $1.37 Million

Daniel Newman Mendelson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 12 2024	BUY Open market or private purchase	$6,500 $6.5 p/Share	1,000 Added 0.5%	198,625 Common Stock
Jan 11 2024	BUY Open market or private purchase	$12,540 $6.27 p/Share	2,000 Added 1.0%	197,625 Common Stock
Jan 10 2024	BUY Open market or private purchase	$18,576 $6.31 p/Share	2,944 Added 1.48%	195,625 Common Stock
Jan 09 2024	BUY Open market or private purchase	$18,750 $6.25 p/Share	3,000 Added 1.53%	192,681 Common Stock
Jan 08 2024	BUY Open market or private purchase	$6,150 $6.15 p/Share	1,000 Added 0.52%	189,681 Common Stock
Jan 05 2024	BUY Open market or private purchase	$12,180 $6.09 p/Share	2,000 Added 1.05%	188,681 Common Stock
Jan 04 2024	BUY Open market or private purchase	$18,360 $6.12 p/Share	3,000 Added 1.58%	186,681 Common Stock
Jan 03 2024	BUY Open market or private purchase	$2,915 $5.83 p/Share	500 Added 0.27%	183,681 Common Stock
Dec 21 2023	BUY Open market or private purchase	$12,300 $4.92 p/Share	2,500 Added 1.35%	183,181 Common Stock
Dec 20 2023	BUY Open market or private purchase	$10,122 $4.82 p/Share	2,100 Added 1.15%	180,681 Common Stock
Dec 19 2023	BUY Open market or private purchase	$23,750 $4.75 p/Share	5,000 Added 2.72%	178,581 Common Stock
Oct 11 2023	BUY Open market or private purchase	$32,000 $6.4 p/Share	5,000 Added 2.97%	163,081 Common Stock
Oct 10 2023	BUY Open market or private purchase	$7,051 $6.41 p/Share	1,100 Added 0.69%	158,081 Common Stock
Oct 06 2023	BUY Open market or private purchase	$9,914 $6.48 p/Share	1,530 Added 0.97%	156,981 Common Stock
Oct 05 2023	BUY Open market or private purchase	$12,940 $6.47 p/Share	2,000 Added 1.27%	155,451 Common Stock
Oct 04 2023	BUY Open market or private purchase	$32,000 $6.4 p/Share	5,000 Added 3.16%	153,451 Common Stock
Oct 03 2023	BUY Open market or private purchase	$15,750 $6.3 p/Share	2,500 Added 1.66%	148,451 Common Stock
Sep 29 2023	BUY Open market or private purchase	$24,640 $6.16 p/Share	4,000 Added 2.25%	173,581 Common Stock
Sep 28 2023	BUY Open market or private purchase	$31,100 $6.22 p/Share	5,000 Added 2.86%	169,581 Common Stock
Sep 27 2023	BUY Open market or private purchase	$8,925 $5.95 p/Share	1,500 Added 0.9%	164,581 Common Stock
Sep 26 2023	BUY Open market or private purchase	$28,250 $5.65 p/Share	5,000 Added 3.31%	145,951 Common Stock
Sep 22 2023	BUY Open market or private purchase	$20,966 $5.5 p/Share	3,812 Added 2.63%	140,951 Common Stock
Sep 21 2023	BUY Open market or private purchase	$27,550 $5.51 p/Share	5,000 Added 3.52%	137,139 Common Stock
Sep 20 2023	BUY Open market or private purchase	$22,139 $5.51 p/Share	4,018 Added 2.95%	132,139 Common Stock
Sep 19 2023	BUY Open market or private purchase	$26,400 $5.28 p/Share	5,000 Added 3.76%	128,121 Common Stock

DNM

Daniel Newman Mendelson

Director

Hackensack, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CSBR shares.

Notify only if

Value

Insider Trading

Get notified when an Champions Oncology, Inc. insider buys or sells CSBR shares.

Notify only if

Operation

Value

Type

News

Receive news related to CHAMPIONS ONCOLOGY, INC.

Track Activities on CSBR

Account